202 related articles for article (PubMed ID: 23216710)
1. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
[TBL] [Abstract][Full Text] [Related]
2. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
Warkentin TE; Cook RJ; Marder VJ; Sheppard JA; Moore JC; Eriksson BI; Greinacher A; Kelton JG
Blood; 2005 Dec; 106(12):3791-6. PubMed ID: 16109780
[TBL] [Abstract][Full Text] [Related]
3. Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
Warkentin TE; Cook RJ; Marder VJ; Greinacher A
J Thromb Haemost; 2010 Mar; 8(3):504-12. PubMed ID: 20050998
[TBL] [Abstract][Full Text] [Related]
4. Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
Bakchoul T; Assfalg V; Zöllner H; Evert M; Novotny A; Matevossian E; Friess H; Hartmann D; Hron G; Althaus K; Greinacher A; Hüser N
J Thromb Haemost; 2014 Jun; 12(6):871-8. PubMed ID: 24655935
[TBL] [Abstract][Full Text] [Related]
5. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.
Gluckman TJ; Segal JB; Schulman SP; Shapiro EP; Kickler TS; Prechel MM; Conte JV; Walenga JM; Shafique I; Rade JJ
J Thromb Haemost; 2009 Sep; 7(9):1457-64. PubMed ID: 19552638
[TBL] [Abstract][Full Text] [Related]
7. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
Warkentin TE; Sheppard JI; Moore JC; Sigouin CS; Kelton JG
J Thromb Haemost; 2008 Aug; 6(8):1304-12. PubMed ID: 18489711
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
9. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
12. Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay.
Althaus K; Strobel U; Warkentin TE; Greinacher A
Thromb Res; 2011 Sep; 128(3):256-60. PubMed ID: 21620439
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
14. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
16. An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.
Eekels JJM; Althaus K; Bakchoul T; Kroll H; Kiefel V; Nazy I; Lee LS; Sachs U; Warkentin TE; Greinacher A
J Thromb Haemost; 2019 Mar; 17(3):525-531. PubMed ID: 30640980
[TBL] [Abstract][Full Text] [Related]
17. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
Visentin GP; Malik M; Cyganiak KA; Aster RH
J Lab Clin Med; 1996 Oct; 128(4):376-83. PubMed ID: 8833886
[TBL] [Abstract][Full Text] [Related]
18. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
20. Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery.
Bito S; Miyata S; Migita K; Nakamura M; Shinohara K; Sato T; Tonai T; Shimizu M; Shibata Y; Kishi K; Kubota C; Nakahara S; Mori T; Ikeda K; Ota S; Minamizaki T; Yamada S; Shiota N; Kamei M; Motokawa S
Blood; 2016 Feb; 127(8):1036-43. PubMed ID: 26659923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
